The drug laquinimod reduced the number of relapses for people with multiple sclerosis (MS), in a large, long-term Phase III clinical study. The study involved 1,106 people with relapsing-remitting MS in 24 countries. The participants received either a once-daily oral…
Day: April 14, 2011
Mayo Clinic Finds Tool to Predict MS Progression
Many patients with progressive multiple sclerosis (MS) worry how quickly the disease will progress. Now, by noting the presence of certain markers in a commonly performed diagnostic test, Mayo Clinic researchers can predict whether patients will suffer a faster onset…
Students Invent Prosthetic Arm
Ryerson biomedical engineering students Michal Prywata and Thiago Caires’ prosthetic arm is controlled by brain signals. Images: James Kachan Two Ryerson University undergraduate biomedical engineering students are changing the world of medical prosthetics with a newly developed…